TwinCapsula Achieves Recognition for Innovative Cold Storage Technology
In a remarkable achievement, TwinCapsula, a venture originating from JAXA, has been awarded the Outstanding Award at the 37th SME New Technology and Product Awards for its innovative product,
BAMBOO SHELLter. The award ceremony took place on April 25 at the Keidanren Kaikan in Chiyoda, Tokyo, where the company received its certificate and accolades from the event organizers, including the Resona Small and Medium Enterprise Promotion Foundation and Nikkan Kogyo Shimbun.
About BAMBOO SHELLter
The BAMBOO SHELLter is a compact, ultra-insulated container designed primarily for cold transport, especially in medical and drug development sectors where maintaining a specific temperature is crucial. By integrating JAXA's re-entry capsule technology, this product can sustain temperature control for over 11 days, significantly minimizing temperature deviation risks and reducing transport costs for sensitive medical specimens.
This award honors the tremendous innovation and commercial viability of the technology. Among a total of 270 applicants, TwinCapsula's product stood out for its outstanding performance and market potential in cold chain logistics, proving to be a game-changer for efficient and cost-effective transport solutions.
Development Journey
BAMBOO SHELLter was developed leveraging the results of JAXA's HTV (H-II Transfer Vehicle) initiative's mini-recovery capsule project, supported by various initiatives including the Next-Generation Technology Utilization Business Innovation Promotion Project in Ibaraki and the Ibaraki Challenge Fund. TwinCapsula advanced the cold retention capabilities of BAMBOO SHELLter through comprehensive R&D, backed by collaborations with firms such as Tiger Corporation, enhancing the product's effectiveness for international transportation needs.
Unique Features of BAMBOO SHELLter
The BAMBOO SHELLter features a sleek, bamboo-like shape and excels at providing high-performance insulation in a compact form factor. This technology meets the challenging requirements of reliable and cost-effective cold transport, making it ideal for scenarios involving small volumes of critical materials, such as vaccines and diagnostic specimens that require frequent long-distance shipping.
It is designed to optimize the temperatures during transit to ensure that sensitive items remain stable throughout their journey. Users interested in the BAMBOO SHELLter are encouraged to explore its capabilities through complimentary trial usage, allowing potential customers to assess its suitability for their specific needs and applications.
Company Vision and Future Directions
TwinCapsula operates under the motto "Bringing the re-entry capsule's ultra-insulation technology to society." The company aims to empower the biomedical sector by enabling personalized cold transport of specimens, pharmaceuticals, and other critical items for clinical research and trials. With strategic partnerships underway, including one with Cooridinate Lab for blood specimen collection in clinical trials, TwinCapsula is poised to push boundaries in cold storage technology further.
The accolades achieved so far, including this recent award and recognition from the NEDO and other initiatives, underscore the company's commitment to excellence and innovation in the field of temperature-sensitive logistics. TwinCapsula is more than a technology provider; they represent a vision for safer, more efficient transport solutions in healthcare and life sciences.
For further details, interested parties can explore the company's offerings and reach out using the contact information available on their official website.